menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Integrating Real-World Evidence into Oncology Practice: A Closer Look at Biosimilars 

Program Information
Recommended

Program Information

ReachMD Healthcare Image
RestartResume

Can real-world evidence on biosimilars help bridge the gap between randomized controlled trial outcomes and clinical practice?

  • Sponsored by

  • Overview

    Even though randomized controlled trials are considered the gold standard for guiding evidence-based therapeutic decisions in the oncology field, there’s a potential gap between those trial outcomes and clinical practice. Could real-world evidence help bridge that gap?

    Find out with Dr. Charles Turck and medical oncology specialist Dr. Jerome Goldschmidt as they discuss the emergence and application of real-world evidence on biosimilars in the oncology field.

    USA-OPAL-80117

Schedule4 Dec 2021
Webpack App